GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
HALOZYME THERAPEUTIC (HALO) [hlAlert]

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the endocrinology, oncology, dermatology and drug delivery markets The Company's products are based on the property covering the family of human enzymes known
as hyaluronidases. The Company has two marketed products: HYLENEX, a product used as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids, and Cumulase, a product used for in vitro fertilization (IVF). The Company has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. (Roche), to apply Enhanze Technology to Roche?s biological therapeutic compounds for up to 13 targets, and with Baxter Healthcare Corporation (Baxter), to apply Enhanze Technology to Baxter?s biological therapeutic compound, GAMMAGARD LIQUID.
.
( Total: 16 Current Stock Recommendations )
HALOZYME THERAPEUTIC   (16)
Sell Buy 88%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
7/24/2007  
Buy
  
9/11/2007  
Sell
  
2/26/2009  
Buy
  
4/29/2009  
Buy
  
10/13/2009  
Buy
  
3/22/2010  
Buy
  
4/8/2010  
Buy
  
10/6/2010  
Buy
  
4/1/2011  
Buy
  
10/18/2011  
Buy
  
8/2/2012  
Sell
  
5/15/2013  
Buy
  
1/8/2015  
Buy
  
3/3/2015  
Buy
  
6/22/2015  
Buy
  
9/22/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy